is trulicity a glp 1 receptor agonists GLP-1 Agonists: The New Wave in Diabetes Management Science Behind GLP 1 GIP

For users this could segway into an expansion of the private market and for payers this could provide an affordable entry point for public reimbursement

Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect

Learn why rapid weight loss on GLP-1 medications can trigger telogen effluvium and how to protect your hair.

Gastroparesis, also known as stomach paralysis, is not typically life-threatening, but complications from the condition can be fatal.